Nick Langworthy

Big milestones deserve special recognition. My office can help you request a Congressional Commendation or Presidential Greeting. Here's how: https://t.co/qRurJNn0TU

The Working Families Tax Cuts that I proudly voted for puts families first with no tax on tips or overtime, a larger Child Tax Credit, expanded tax relief for seniors and a higher standard deduction. More of every hard-earned paycheck stays where it belongs: with the families who earned it.

The best solutions for families happen when Republicans and Democrats work together on common sense solutions. I'm proud to reach across the aisle to cosponsor the bipartisan Celiac Safety Act. It's a no-brainer. This bill strengthens food labeling protections and helps families live healthier, safer lives.

Growing up in Jamestown and Chautauqua County was a blessing that shaped who I am today. The people, values, and community will always be part of me. Representing my hometown in Congress is the honor of a lifetime. https://t.co/dUdSNNNEon

Hochul and Albany Democrats made their disastrous green new deal the law of the land in NY and now they want to take it nationwide. I'm proud to be the tip of the spear on this fight against expensive, dangerous electrification mandates because we know all too well what's at stake. #bantheban

The same boldness that sent Christopher Columbus across an uncharted ocean lives in the American spirit today. The courage to explore. The bravery to dream. The determination to achieve the impossible. That's the spirit that makes America great. Happy Columbus Day. https://t.co/HSbJym3Ldo

Everyday, my office helps thousands of residents across Western New York and the Southern Tier cut through the red tape and get them the federal services they need. That's what I'm here for and there is nothing more gratifying than helping a senior get her Social Security or a veteran get the care they need. It's my honor to serve. Visit my website here for more info: https://t.co/l5N9aqS5Tp

When you put in a hard day's work, big government shouldn't take an even bigger bite out of your paycheck--especially to pay for waste, fraud, and abuse. You deserve to keep more of your hard-earned income and that's why I fought so hard to eliminate taxes on overtime. My priority is to make sure the people who pay the bills in this country are respected again.

Federal grants can help firefighters, small towns and community based organizations across NYS. I want to help bring those dollars home to our neck of the woods. My office is here to help you find funding and apply. Here's how: https://t.co/mru2pYi9Rp

ICYMI from Clarence Center Volunteer Fire Company: Firefighters face a 62% higher risk of esophageal cancer. Early detection saves lives. I'm fighting in Washington for expanded cancer screenings, treatments and safer protective gear for our firefighters. https://t.co/jht6ZzUKq0

No problem is too big and no problem is too small for our office to help you with. Our mission: cut through the red tape so you get the effective, efficient government you deserve and pay for. If you’re struggling with Social Security, veterans benefits, passports, the IRS or another federal agency, my team and I are here to help. Click here and let us go to work for you: https://t.co/TsngR8TfW8

Today, we remember the innocent lives killed by maniacal terrorists on October 7th, 2023. We honor every innocent soul lost, every family shattered, and every loved one who was horrifically murdered by tyrannical cowards. May their memories be a blessing. We will never forget them. America stands strong with the Jewish people here at home and around the world. We must be united against the scourge of antisemitism.

No Tax on Tips puts more hard-earned money directly back into your pocket. Waitresses, bartenders, drivers, hairdressers and other hardworking Americans can deduct up to $25,000 in qualified tips. That’s real relief for blue collar families. I was proud to help make this law to help working and middle class families keep more of their hard-earned income.

I really appreciate the kind words from @WHAM1180's @BobLonsberry. My guiding principle in making decisions: is this best for the families I serve in NY23? https://t.co/pV7BZY784o

I'm so proud to fight for our farmers. My Dairy Farm Resiliency Act strengthened the Dairy Margin Coverage program. It protects up to 6 million pounds of milk when prices drop or feed costs soar. This helps family farms thrive and keeps food on our tables. https://t.co/mJW5LmRSxf

If you're planning a trip to Washington my office can help NY-23 families request tours of the U.S. Capitol and White House. Please visit my website to submit a request. Details are right here: https://t.co/oRV8XF5FPq

🇺🇸 Calling our next generation of American leaders. Our office is offering important information on serving our great nation at one of five military service academies. Join my virtual information session October 7th at 3 PM. Details here: https://t.co/mvNZ7ir7va

https://t.co/S4X9CN5ms9

Registration is now open for the 2026 Congressional App Challenge. America’s next great innovator could be right here in NY23. If you're a young coder, click this link to apply. The deadline is October 26th. https://t.co/LGesyOSuxy

You deserve the best possible health outcomes without going broke to pay for it. My bipartisan Biosimilars Access and Affordability Act expands access to the strongest treatments on the market, increases competition and helps drive down prescription drug costs for families. https://t.co/yOvkN5hD6m

As a father, this interview with @TGowdySC is a gut punch. “There is nothing worse than having to go to a coroner's office and identifying the body of your daughter.” This is Jessica and Thomas Gorman. Their daughter Sheridan was killed by an illegal immigrant. The failed, wide open border policies of @KathyHochul were mentioned in this clip. Don't ever forget, Hochul's very first Executive Order cemented NYS as a Sanctuary State. Hochul and radical progressive politicians who fight for illegal immigrants should watch and listen to this gut wrenching interview. God bless this family.

ICYMI from the Clarence Bee: I was joined by Jim and Jill Kelly, who are partnering in our noble mission to expand lifesaving newborn screenings. Our bipartisan bill provides $35 million every year to save babies by helping states detect serious conditions sooner. https://t.co/T65guijDQF

Serving our great nation is one of our highest callings. Our office accepts applications from NY23 students seeking nominations to West Point, the Naval Academy, Air Force Academy and Merchant Marine Academy. Click here for details: https://t.co/KaqQMW1T5o

I'm proud to invest in the brave firefighters who put their lives on the line to save ours. In Washington I helped deliver critically important resources for multiple volunteer fire companies: $97,142 for Sinclairville, $70,714 for Olean and $50,988 for Kiantone. https://t.co/x5MNJdLEAh

Washington, D.C. —October 2nd… Congressman Nick Langworthy today announced the introduction of the Biosimilars Access and Affordability Act, bipartisan legislation to expand access to lower-cost biosimilar prescription drugs and help bring them to market. The legislation updates Medicare policy to provide a clearer pathway for lower-cost biosimilar medicines that are actively moving toward the market, while protecting Medicare if those anticipated competitors never reach patients. Senator Marsha Blackburn (R-TN) is leading the companion bill in the U.S. Senate. Biosimilars are highly similar versions of biologic medicines that can provide additional treatment options and introduce competition into markets where patients may have limited choices. By encouraging legitimate biosimilar competition, the legislation aims to expand access to treatments and help put downward pressure on drug costs. “Competition is one of the most powerful tools we have to drive innovation and affordability in our healthcare system and biosimilars have helped give millions of patients access to lifesaving drugs at lower costs,” said Congressman Nick Langworthy. “But time is of the essence when dealing with a disease or illness and patients should not have to pay more simply because a lower-cost competitor is on the way, but the rules governing Medicare don't adequately account for it. Our legislation takes a straightforward approach that if a biosimilar is genuinely moving through the FDA process and toward the market, it should have a fair opportunity to compete. At the same time, Medicare should not be left waiting indefinitely if that competition never materializes. This is good for patients, good for research and development, and good for the Medicare system.” Under current law, Medicare can temporarily delay selecting an original biologic drug for price negotiation when a lower-cost biosimilar competitor is expected to enter the market. While the existing policy can allow for a delay of up to two years, it generally operates through separate one-year determinations and has narrow and complicated criteria for qualifying biosimilars. The Biosimilars Access and Affordability Act would maintain the existing two-year maximum while creating a clearer and more predictable process for determining when an approaching biosimilar qualifies for the temporary delay. Specifically, the legislation would: Simplify the existing two-year delay process by establishing a clearer pathway for qualifying biosimilars rather than relying primarily on separate one-year determinations. Recognize concrete evidence that a biosimilar is moving toward the market, including FDA acceptance or approval of an application and required clinical studies that are underway, completed or determined to be unnecessary. Require manufacturers to certify their expected launch information, with legal consequences for knowingly providing false information. Preserve another pathway for strong cases, allowing a manufacturer to seek a delay when it can provide compelling evidence that its biosimilar is highly likely to reach the market. An ongoing patent lawsuit alone would not disqualify a biosimilar. Protect Medicare if anticipated competition never arrives. If a biosimilar is not approved and marketed within the two-year period, the original biologic would enter Medicare's negotiation program, and its manufacturer would owe rebates covering the period during which the negotiated price otherwise would have been in effect. The legislation is also co-led by Reps. Jake Auchincloss (D-MA), John Joyce (R-PA), Linda Sánchez (D-CA), Scott Peters (D-CA), Rudy Yakym (R-IN), Nathaniel Moran (R-TX) as well as original cosponsors, Rep. Mullin (D-CA) and Rep. Panetta (D-CA). Rep. Jake Auchincloss said, “Healthcare premiums are too expensive — going up by more than 10% for employees in Massachusetts. Bringing more biosimilars to market helps lower those premiums for Bay Staters.” "This legislation provides certainty for the future development of biosimilars,” said Rep. Nathaniel Moran. “Biosimilars are vital to our healthcare ecosystem as they provide lower-cost options for patients and produce significant savings for taxpayers. East Texans deserve access to lower drug prices, and I'm glad to co-lead this with Congressman Langworthy.” “As a physician legislator, I know that innovation is the cornerstone of American medicine,” said Congressman John Joyce, M.D. “Maintaining incentives to develop and bring biosimilars to the market helps deliver effective treatments to patients at a lower cost. This legislation is a pro-patient and pro-innovation solution to a harmful consequence of the IRA drug pricing negotiation program.” Congressman Scott Peters said, “Biologics are critical to treating serious illnesses like cancer, autoimmune diseases and genetic disorders, but they are also some of the most expensive drugs on the market. Biosimilars have cut biologic prices by up to 85 percent, yet only a small fraction of name-brand biologics have biosimilars in development. Our bill preserves the biosimilar pathway while incentivizing new development. Red tape should not stand between patients and affordable access to the cutting-edge treatments they need.” The Biosimilars Access and Affordability Act is supported by the Alliance for Aging Research, Arthritis Foundation, Eosinophilic & Rare Disease Cooperative, Community Access National Network, Global Healthy Living Network, International Cancer Advocacy Network, International Pemphigus and Pemphigoid Foundation, Lupus and Allied Diseases Association, Inc., and Roswell Park. “For people facing cancer, access to the right treatment at the right time is incredibly important. Roswell Park is grateful to Congressman Langworthy for his leadership in advancing this smart proposal to expand access to effective cancer therapies while improving affordability for patients and our health care system.” --Candace S. Johnson, PhD, President and CEO, Roswell Park Comprehensive Cancer Center “Biosimilars play an increasingly effective role in the fight against cancer and greatly help with the side effects of treatment. The Biosimilars Access and Affordability Act will increase the number of biosimilars available and reduce costs for patients. It's an important bill which all people fighting cancer and other lethal and chronic diseases should strongly support.” --Marcia K. Horn, JD, President and CEO, ICAN, International Cancer Advocacy Network “Patients living with eye disease deserve to be at the center of every treatment decision, with access to the full range of safe, effective and affordable options available to them and their providers. Biosimilars can play an important role in expanding access and affordability, but lower cost should never come at the expense of effectiveness, patient outcomes, or the ability to choose the treatment that is right for them. Prevent Blindness supports policies that put patients first—expanding access and choice today while preserving the innovation necessary to develop the sight-saving treatments of tomorrow.” --Kira Baldonado, Executive Vice President of Prevent Blindness "For people managing a rare disease, access isn't abstract — it's not just about the medicine that is keeping them stable now, but what is next. Biosimilars are an important part of the treatment landscape, and we should prioritize access to all treatment options." –Sarah Jones, Eosinophilic Rare Disease Coalition Casey McPherson, Executive Director of the Alliance for Patient Access said, “Biosimilars give patients and physicians more affordable options for treating serious and chronic conditions. But unclear rules around Medicare's biosimilar delay provision are discouraging the investment needed to bring these treatments to market. The Biosimilars Access and Affordability Act restores the law's original intent with clear, predictable standards. The Alliance for Patient Access is proud to support this legislation."